Glatiramer acetate multiple sclerosis relapsing remitting. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Myelin Sheath Th2 Cells Brain Spinal Cord Oligodendroglia Central Nervous System Nerve Fibers, Myelinated Axons T-Lymphocytes Cerebrospinal Fluid Microglia Optic Nerve Cells, Cultured Blood-Brain Barrier

Organisms2

Mice, Inbred C57BL Theilovirus

Diseases24

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Genetic Diseases, Y-Linked Encephalomyelitis, Autoimmune, Experimental Multiple Sclerosis, Chronic Progressive Sclerosis Recurrence Disease Progression Amyotrophic Lateral Sclerosis Tuberous Sclerosis Demyelinating Diseases Disease Models, Animal Optic Neuritis Scleroderma, Systemic Neuromyelitis Optica Atrophy Encephalomyelitis, Acute Disseminated Diffuse Cerebral Sclerosis of Schilder Demyelinating Autoimmune Diseases, CNS Nervous System Diseases Autoimmune Diseases Cardiovirus Infections Fatigue Remission, Spontaneous

Chemicals and Drugs27

Peptides Immunosuppressive Agents Interferon-beta Adjuvants, Immunologic Immunologic Factors Myelin Basic Protein Acetates Neuroprotective Agents Cytokines Tetradecanoylphorbol Acetate Oligoclonal Bands Fumarates Myelin-Oligodendrocyte Glycoprotein Myelin Proteins Myelin-Associated Glycoprotein Myelin Proteolipid Protein Acetate Kinase HLA-DR2 Antigen Sodium Acetate Propylene Glycols Cuprizone Medroxyprogesterone Acetate HLA-DRB1 Chains Cerebrospinal Fluid Proteins Cyproterone Acetate Methylprednisolone Megestrol Acetate

Analytical, Diagnostic and Therapeutic Techniques and Equipment10

Encephalomyelitis, Autoimmune, Experimental Injections, Subcutaneous Treatment Outcome Magnetic Resonance Imaging Disease Models, Animal Double-Blind Method Disability Evaluation Case-Control Studies Severity of Illness Index Neurologic Examination

Phenomena and Processes3

Time Factors Remission, Spontaneous Autoimmunity

Health Care6

Treatment Outcome Double-Blind Method Intention to Treat Analysis Case-Control Studies Severity of Illness Index Age of Onset

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Peptides Genetic Diseases, Y-Linked Immunosuppressive Agents Interferon-beta Encephalomyelitis, Autoimmune, Experimental Adjuvants, Immunologic Immunologic Factors Myelin Basic Protein Multiple Sclerosis, Chronic Progressive Acetates Myelin Sheath Sclerosis Injections, Subcutaneous Neuroprotective Agents Recurrence Th2 Cells Disease Progression Amyotrophic Lateral Sclerosis Treatment Outcome Tuberous Sclerosis Magnetic Resonance Imaging Demyelinating Diseases Disease Models, Animal Cytokines Brain Mice, Inbred C57BL Double-Blind Method Optic Neuritis Tetradecanoylphorbol Acetate Scleroderma, Systemic Oligoclonal Bands Intention to Treat Analysis Fumarates Myelin-Oligodendrocyte Glycoprotein Spinal Cord Disability Evaluation Myelin Proteins Oligodendroglia Myelin-Associated Glycoprotein Neuromyelitis Optica Central Nervous System Myelin Proteolipid Protein Atrophy Acetate Kinase HLA-DR2 Antigen Sodium Acetate Encephalomyelitis, Acute Disseminated Case-Control Studies Propylene Glycols Cuprizone Nerve Fibers, Myelinated Diffuse Cerebral Sclerosis of Schilder Demyelinating Autoimmune Diseases, CNS Severity of Illness Index Axons Theilovirus Medroxyprogesterone Acetate Nervous System Diseases T-Lymphocytes Age of Onset Cerebrospinal Fluid HLA-DRB1 Chains Cerebrospinal Fluid Proteins Microglia Cyproterone Acetate Time Factors Optic Nerve Autoimmune Diseases Cells, Cultured Cardiovirus Infections Methylprednisolone Neurologic Examination Fatigue Megestrol Acetate Remission, Spontaneous Autoimmunity Blood-Brain Barrier

No FAQ available that match "glatiramer acetate multiple sclerosis relapsing remitting"